{
  "id": "resp_083db363902c48dd00693c8ebd63588193bb082682ff0b5e18",
  "object": "response",
  "created_at": 1765576381,
  "status": "completed",
  "background": false,
  "billing": {
    "payer": "developer"
  },
  "error": null,
  "incomplete_details": null,
  "instructions": null,
  "max_output_tokens": null,
  "max_tool_calls": null,
  "model": "gpt-5.2-2025-12-11",
  "output": [
    {
      "id": "rs_083db363902c48dd00693c8ebdb58c8193acaa020414d0bc7e",
      "type": "reasoning",
      "summary": []
    },
    {
      "id": "ws_083db363902c48dd00693c8ed23bdc8193b732ca725167d7e1",
      "type": "web_search_call",
      "status": "completed",
      "action": {
        "type": "search",
        "query": "site:clinicaltrials.gov CDK12 inhibitor triple negative breast cancer"
      }
    },
    {
      "id": "rs_083db363902c48dd00693c8ed41f20819387fd66b2f910a33a",
      "type": "reasoning",
      "summary": []
    },
    {
      "id": "ws_083db363902c48dd00693c8edbdd5481939c14e7dee9726b32",
      "type": "web_search_call",
      "status": "completed",
      "action": {
        "type": "search",
        "query": "site:clinicaltrials.gov CDK12/13 inhibitor NCT"
      }
    },
    {
      "id": "rs_083db363902c48dd00693c8ede2f708193be50db8428ec3db2",
      "type": "reasoning",
      "summary": []
    },
    {
      "id": "ws_083db363902c48dd00693c8edeacf88193af26120f52ea4b20",
      "type": "web_search_call",
      "status": "completed",
      "action": {
        "type": "open_page",
        "url": "https://clinicaltrials.gov/study/NCT06600789"
      }
    },
    {
      "id": "rs_083db363902c48dd00693c8edf54dc8193bba75748a0538030",
      "type": "reasoning",
      "summary": []
    },
    {
      "id": "ws_083db363902c48dd00693c8ee2e1b88193b9addf1217d17706",
      "type": "web_search_call",
      "status": "completed",
      "action": {
        "type": "open_page"
      }
    },
    {
      "id": "rs_083db363902c48dd00693c8ee3b6ac8193924feed9b2638861",
      "type": "reasoning",
      "summary": []
    },
    {
      "id": "ws_083db363902c48dd00693c8ee49fa08193bcc02bc5d663451b",
      "type": "web_search_call",
      "status": "completed",
      "action": {
        "type": "search",
        "query": "NCT06600789 ct2 show"
      }
    },
    {
      "id": "rs_083db363902c48dd00693c8ee680d08193afd011f965d2f64b",
      "type": "reasoning",
      "summary": []
    },
    {
      "id": "ws_083db363902c48dd00693c8eec8a108193b75ff2d8835fb40d",
      "type": "web_search_call",
      "status": "completed",
      "action": {
        "type": "search",
        "query": "clinicaltrials.gov api v2 studies NCT06600789"
      }
    },
    {
      "id": "rs_083db363902c48dd00693c8eee99548193b4b5c7639084db19",
      "type": "reasoning",
      "summary": []
    },
    {
      "id": "ws_083db363902c48dd00693c8ef300c08193837d0159f19ac504",
      "type": "web_search_call",
      "status": "completed",
      "action": {
        "type": "search",
        "query": "api/v2/studies/NCT06600789"
      }
    },
    {
      "id": "rs_083db363902c48dd00693c8ef5f948819380fce77a86eac8ad",
      "type": "reasoning",
      "summary": []
    },
    {
      "id": "ws_083db363902c48dd00693c8efe7ff4819383d61f0f608ed17c",
      "type": "web_search_call",
      "status": "completed",
      "action": {
        "type": "search",
        "query": "Study Details NCT06600789 ClinicalTrials.gov"
      }
    },
    {
      "id": "rs_083db363902c48dd00693c8f01161881938c958a1d3342a27e",
      "type": "reasoning",
      "summary": []
    },
    {
      "id": "ws_083db363902c48dd00693c8f32c07481938238de6d930d4e73",
      "type": "web_search_call",
      "status": "completed",
      "action": {
        "type": "open_page",
        "url": "https://www.carricktherapeutics.com/pipeline/cdk1213-inhibitor"
      }
    },
    {
      "id": "rs_083db363902c48dd00693c8f339244819391250a597763edde",
      "type": "reasoning",
      "summary": []
    },
    {
      "id": "ws_083db363902c48dd00693c8f39e41c8193a4269012e36ac5fe",
      "type": "web_search_call",
      "status": "completed",
      "action": {
        "type": "search",
        "query": "site:clinicaltrials.gov CT7439"
      }
    },
    {
      "id": "rs_083db363902c48dd00693c8f3c488081939e2c84c154dfc593",
      "type": "reasoning",
      "summary": []
    },
    {
      "id": "ws_083db363902c48dd00693c8f5745e081938a91608d68e91ff3",
      "type": "web_search_call",
      "status": "completed",
      "action": {
        "type": "search",
        "query": "NCT06600789"
      }
    },
    {
      "id": "rs_083db363902c48dd00693c8f5a7b108193906c14d12b98536d",
      "type": "reasoning",
      "summary": []
    },
    {
      "id": "ws_083db363902c48dd00693c8f9ae67c8193b47ccecaacb577d1",
      "type": "web_search_call",
      "status": "completed",
      "action": {
        "type": "open_page",
        "url": "https://cdek.pharmacy.purdue.edu/trial/NCT06600789/"
      }
    },
    {
      "id": "rs_083db363902c48dd00693c8f9c632c81939aadbaca230aae50",
      "type": "reasoning",
      "summary": []
    },
    {
      "id": "ws_083db363902c48dd00693c8fa224108193ac27c8e532237104",
      "type": "web_search_call",
      "status": "completed",
      "action": {
        "type": "open_page",
        "url": "https://trial.medpath.com/clinical-trial/e9357df4650cb6b7/nct06600789-safety-tolerability-ct7439-solid-malignancies"
      }
    },
    {
      "id": "rs_083db363902c48dd00693c8fa328c081939e0436b025379d2a",
      "type": "reasoning",
      "summary": []
    },
    {
      "id": "ws_083db363902c48dd00693c8fa3fa608193a00de0b940bb7b68",
      "type": "web_search_call",
      "status": "completed",
      "action": {
        "type": "search"
      }
    },
    {
      "id": "rs_083db363902c48dd00693c8fa565248193bc6408fdd41f9d7c",
      "type": "reasoning",
      "summary": []
    },
    {
      "id": "ws_083db363902c48dd00693c8fa5c8c48193bc80fadb5313350a",
      "type": "web_search_call",
      "status": "completed",
      "action": {
        "type": "find_in_page",
        "pattern": "Trial Locations",
        "url": "https://trial.medpath.com/clinical-trial/e9357df4650cb6b7/nct06600789-safety-tolerability-ct7439-solid-malignancies"
      }
    },
    {
      "id": "rs_083db363902c48dd00693c8fa8619c81939fee7f9994f3e039",
      "type": "reasoning",
      "summary": []
    },
    {
      "id": "ws_083db363902c48dd00693c8fb440988193becb932c74f6b8ef",
      "type": "web_search_call",
      "status": "completed",
      "action": {
        "type": "search",
        "query": "\"CDK12\" inhibitor\" ClinicalTrials.gov\" breast"
      }
    },
    {
      "id": "rs_083db363902c48dd00693c8fb79ff88193bc80f8ffc8af8b85",
      "type": "reasoning",
      "summary": []
    },
    {
      "id": "ws_083db363902c48dd00693c8fc867608193bebc6cec2b171b9b",
      "type": "web_search_call",
      "status": "completed",
      "action": {
        "type": "open_page",
        "url": "https://clinicaltrials.gov/study/NCT06600789"
      }
    },
    {
      "id": "rs_083db363902c48dd00693c8fc9b74c819397a66a60cd4235fd",
      "type": "reasoning",
      "summary": []
    },
    {
      "id": "ws_083db363902c48dd00693c8fd8ca4c8193aaa7acd9c938a59a",
      "type": "web_search_call",
      "status": "completed",
      "action": {
        "type": "search",
        "query": "\"CDK12\" inhibitor \"Phase 1\" trial drug"
      }
    },
    {
      "id": "rs_083db363902c48dd00693c8fde9e9c81939674d11afe45bff4",
      "type": "reasoning",
      "summary": []
    },
    {
      "id": "msg_083db363902c48dd00693c8ffe55688193ad27830c570331fa",
      "type": "message",
      "status": "completed",
      "content": [
        {
          "type": "output_text",
          "annotations": [],
          "logprobs": [],
          "text": "{\n  \"validated\": false,\n  \"assets\": [],\n  \"rejected_reason\": \"Candidate identifier 'ClinicalTrials.gov' is a clinical trial registry website (https://clinicaltrials.gov/), not a specific drug name/code, trial ID (e.g., NCT number), patent ID, or other unique asset identifier; therefore required fields (sponsor/target/modality/indication/stage/geography) cannot be attributed to a single drug asset.\"\n}"
        }
      ],
      "role": "assistant"
    }
  ],
  "parallel_tool_calls": true,
  "previous_response_id": null,
  "prompt_cache_key": null,
  "prompt_cache_retention": null,
  "reasoning": {
    "effort": "xhigh",
    "summary": null
  },
  "safety_identifier": null,
  "service_tier": "default",
  "store": true,
  "temperature": 1.0,
  "text": {
    "format": {
      "type": "text"
    },
    "verbosity": "medium"
  },
  "tool_choice": "auto",
  "tools": [
    {
      "type": "web_search",
      "filters": null,
      "search_context_size": "medium",
      "user_location": {
        "type": "approximate",
        "city": null,
        "country": "US",
        "region": null,
        "timezone": null
      }
    }
  ],
  "top_logprobs": 0,
  "top_p": 0.98,
  "truncation": "disabled",
  "usage": {
    "input_tokens": 69979,
    "input_tokens_details": {
      "cached_tokens": 4736
    },
    "output_tokens": 15618,
    "output_tokens_details": {
      "reasoning_tokens": 15517
    },
    "total_tokens": 85597
  },
  "user": null,
  "metadata": {}
}